Also in 2021, plenty of research has been done by the AGEhIV Cohort Study group. Firstly, AGEhIV study physician Sebastiaan Verboeket wrote an article on weight gain after switching to an integrase inhibitor (a particular class of HIV medication) in AGEhIV study participants. No difference…
Read More
As of 1 March 2021 the second study visit of the COVID-19 sub study will start. Participants of this sub study will receive information about this second visit in advance by mail of post. During the study visit our staff will wear facemasks and the…
Read More
Over the last three decades, we have witnessed tremendous progress in HIV care. Millions of people all over the world are now living longer with HIV thanks to antiretroviral treatment (ART). While they are living to older ages, research has shown that these people have…
Read More
Do people living with HIV age more quickly, despite the fact that their infection is well controlled by antiretroviral treatment? Concerns have emerged in recent years, and the COBRA study was launched to look into the matter by exploring links with age-related conditions, with a…
Read More
Friday January 27 2017 two AGEhIV research-physicians, Judith Schouten and Katherine Kooij, successfully defended their PhD-theses. The day prior to their PhD defenses unexpectedly considerable media attention was given to the results of the study, such as during the Dutch public news broadcasting agency (NOS)…
Read More
Both HIV-related factors as well as factors indirectly or not related to HIV may play a role in the development of cognitive disorders in HIV-positive patients.
Read More
High blood pressure is more prevalent among HIV-positive participants. This might be the result of a larger waist-to-hip ratio in HIV-positive participants.
Read More
